Leber's hereditary optic neuropathy is a neuro-ophthalmological entity characterized by acute or subacute bilateral, not simultaneous visual loss with centro cekal scotoma and occasional further visual improvement. This rare ophthalmological disease can be accompanied with dyschromatopsia. It is associated with a matrilineal inheritance pattern. Its diagnosis used to be solely clini¬cal, aided by imaging and neuro-physiological studies, until the advent of descriptions of mitochondrial biochemical abnormalities and genetic testing. We describe a case of 24 year old male with progressive painless deterioration of visual acuity and positive family history.
Introduction
Leber's hereditary optic neuropathy is a neuroophthalmological entity characterized by acute or subacute bilateral, not simultaneous visual loss with centro cekal scotoma and occasional further visual improvement. Th is rare ophthalmological disease can be accompanied with dyschromatopsia. It is associated with a matrilineal inheritance pattern. Its diagnosis used to be solely clinical, aided by imaging and neuro-physiological studies, until the advent of descriptions of mitochondrial biochemical abnormalities and genetic testing. Primary point mutations occur at nucleotide positions 3460, 11778 and 14484 of the mitochondrial genome coding for protein subunits of the respiratory chain complexes. Th e 11778 mutation is most frequently observed, accounting for 80-90% of described cases.2 Young males are primarily aff ected (80-90%), usually in their third decade of life. Females, carriers of the disease, rarely express the symptoms.
Case report
A young man adult of 24 experienced a sudden progressive, painless decreasing of visual acuity of the right eye. Th e condition deteriorated over a few days. He also noticed that the colors when viewed with the right eye, were extremely pale. Th e left on the fi rst examination was with normal visual acuity. For 22 days visual acuity of the left eye decreased. He had a healthy younger brother, with no visual disturbances. His mother remembered that his uncle (her brother) was 23 years old and had similar problem Th e patient did not smoke, nor did he consume any alcohol and was well nourished. He was not exposed to heavy metals. At the time of the referral, two months aft er the onset of the disease, visual acuity was 0.01 in the right eye, and 0.1 in the left . During visual fi eld testing, centrocoecal scotoma on the right eye and central scotoma on the left eye were found ( Figure  1 ). Subjectively present profound dyschromatopsia could not be objectively proved due to very low central vision. Pupillary responses were normal, and relative aff erent pupillary defect could not be detected. Th ere were no signs of intraocular infl ammation and intraocular pressure was normal. Fundoscopic appearance was not impressive. Th e only thing that could be seen was slightly tortuous papillary capillary network and very discrete dilatation and tortuosity of small peripapillary vessels, more pronounced on the right eye. On fl uorescein angiography, the vessels were intact, with no leakage ( Figure 2 . Th e purpose of this supplementation was to improve cellular ATP usage.
Discussion
Hereditary optic neuropathies are a group of diseases with defi ned clinical presentation and diff erent inheritance patterns. Th e clinical setting may be of acute, sub-acute or relentlessly progressive painless visual loss, bilateral (simultaneous or sequential), with centro cecal scotoma, altered color perception (dyschromatopsia) and optic atrophy. Th e inheritance pattern may present as autosomal dominant, recessive, X-linked or matrilineal (1). In Leber's hereditary optic neuropathy, male individuals in their teens or twenties suff er acute visual loss that is sequential in 78% of cases and simultaneous in 22% (2) . Fundus examination in the initial stages shows papilledema and peripapillary microangiopathy, evolving to atrophy of the nerve fi ber layer of the retina and fi nally leading to optic atrophy and centrocecal scotoma (3). Family history is suggestive of maternal inheritance in 50% of patients, and in the other 50% the disease seems to be sporadic (4 with smoking as the most common factor (9). Multiple sclerosis (or MS-like disease) shares a rather uncommon comorbidity with Leber's hereditary optic neuropathy. Some patients with Leber's hereditary optic neuropathy develop clinical features that are phenotypically indistinguishable from multiple sclerosis, and mutations for Leber's neuropathy are considered to be a risk factor in the pathophysiology of multiple sclerosis (10, 11) . On the other hand, prevalence studies among multiple sclerosis patients have failed to demonstrate primary mtDNA mutations (12, 13) . It is currently recommended to proceed with mt DNA analysis for all young male multiple sclerosis patients with initial neuro-ophthalmological manifestations and peripapillary microangiopathy, especially those with bilateral symptoms and a positive family history for visual los (14) . Th ere is no specifi c treatment for Leber's hereditary optic neuropathy. From an empirical standpoint, most if not all patients will receive an initial diagnosis of optic neuritis and will be treated, without any response, using steroid therapy at high doses. In a case-control study with patients carrying mutations 14484, 3460 and 11778, combination therapy using idebenone / vitamin B2/vitamin C (which improves ATP availability) shortened the time required for vision recovery in the group using this therapy (11.1 months), in comparison with the placebo group (17.4 months; p = 0.03) (15) . A single-patient study backed by magnetic resonance spectroscopy of the central nervous system (31P-MRS) showed clinical and imaging improvement When idebenone treatment was instituted (idebenone is not available in Brazil, but only in Argentina: its action is similar to that of the coenzyme Q10) (16) . Th e prognosis for vision recovery depends on the mutation reported. Good prognosis may be found in up to 50% of patients bearing the 14484 mutation. Nevertheless, only 4% of patients with the 11778 mutation have gradual improvement, as we were able to observe in our patient (17) .
Conclusion
A diagnosis of Leber's hereditary optic neuropathy should be suspected whenever young males develop bilateral visual loss, usually sequential, with a positive familial history. Neuro-ophthalmological examination may demonstrate suggestive signs of Leber's hereditary optic neuropathy. Th e mutation at the 11778 locus is the most frequent mutation of mitochondrial DNA in Leber's hereditary optic neuropathy patients.
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